Ads
related to: t cells- Cell Therapy Handbook
Learn the major considerations for
cell therapy manufacturing success.
- Resources Hub
Discover cell therapy webinars,
app notes, best practices and more.
- Products & Solutions
Find the best media, reagents, and
instruments to scale your workflow.
- 24h CAR T Process Webinar
Learn a new approach to shorten
the CAR T manufacturing timeline.
- Request a Quote
Bundle your cell therapy
manufacturing instruments and save
- Request a Demo
Automate your manufacturing process
using closed, modular instruments.
- Cell Therapy Handbook
Search results
Biotech faces a reckoning: ‘We've lost our luster in cell therapies’
FierceBiotech· 19 hours agoThis story is the first part in a four-part series about cell therapy, created by the Fierce Biotech...
The top 16 foods to boost your immunity — and a dietitian's No. 1 pick to start eating today
Today· 6 days agoWhat's more, a new variant of COVID is taking over and may lead to a summer surge. The good news is...
YOUR HEALTH: New hope for Non-Hodgkin’s Lymphoma patients
WAFB Baton Rouge· 2 days agoNon-Hodgkin’s lymphoma, or NHL, is one of the most common cancers – one in 43 men and one in 53...
Immunocore advances melanoma trial to phase 3 after FDA talks By Investing.com
Investing.com· 15 hours agoOXFORDSHIRE, England & CONSHOHOCKEN, PA & ROCKVILLE, MD - Immunocore Holdings plc (NASDAQ:IMCR), a...
Pipeline Moves: Phase III AML trial fails to meet primary endpoint
Clinical Trials Arena via Yahoo Finance· 2 days agoThis week on Pipeline Moves, we kick off by looking at a Phase III trial of GlycoMimetics’...
Finally, a Treatment Emerges for Autoimmune Polyendocrine Syndrome
MedPage Today· 1 day agoAutoimmune polyendocrine syndrome type 1 (APS-1) responded to ruxolitinib (Jakafi) in a small study,...
Algine Plus Astaxanthin: Your Ultimate Ally This Summer
Digital Journal· 2 days agoPRESS RELEASE Published May 28, 2024 PRUnderground (PRUnderground) May 28th, 2024 As summer approaches, Algine Plus proudly introduces Algine Plus Astaxanthin, a powerful antioxidant designed ...
New Study Shows Regular Exercise May Help Slow The Cognitive Decline Of Aging
MadameNoire· 20 hours agoAccording to a new study conducted by researchers from the University of Queensland in Australia,...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 6 days agoCHS-114 shown to have an acceptable safety profile with no dose-limiting toxicities (DLTs) in heavily pretreated patients with solid tumors Selective depletion of peripheral CCR8+ regulatory T cells (Tregs) was observed and depletion was maintained
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 6 days agoHOOKIPA to present an oral abstract at the American Society for Clinical Oncology (ASCO) 2024 Annual Meeting on June 4Updated data of HB-200 plus pembrolizumab demonstrate a favorable safety profile and promising clinical activity In a subset
Ad
related to: t cells